 report first successful use BMT treatment RBC pyruvate kinase (PK) deficiency boy developed neonatal jaundice severe transfusion-dependent hemolytic anemia months birth. received BMT age 5 HLA-identical sister normal PK activity conditioning busulfan cyclophosphamide. post-transplant course uneventful. present, 3 years transplant, 8 years old normal hemoglobin level normal RBC PK activity without evidence hemolysis. DNA analysis confirmed full engraftment.